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Abstract
Objectives: To evaluate antibacterial efficacies of 21
medicinal plants used by an Indian aboriginal tribe
against infectious diseases caused by bacteria isolated
from clinical samples.
Methods: Standard biochemical procedures were fol-
lowed for identifying bacteria that were isolated from
several clinical samples. All of the bacterial strains were
subjected to antibiotic sensitivity tests by KirbyeBauer’s
disc diffusion method. From antibiograms of isolated
Gram-positive and Gram-negative bacteria, it was
discernible that samples were multidrug resistant (MDR).
The methanol leaf-extract of Solanum xanthocarpum was
subjected to thin layer chromatography (TLC) for
phytochemical analysis. Molecular docking of b-lacta-
mase enzyme of Escherichia coli with phytochemicals of
S. xanthocarpum was performed to locate effective
compounds.
Results: The most effective 5 plants, which caused the
size of the zone of inhibition to range from 21 to 27 mm,
were Buchanania latifolia, Careya arborea, Ocimum ten-
uiflorum, Senna alata and S. xanthocarpum, for MDR
bacteria. S. xanthocarpum had the lowest MIC value of
0.67 mg/ml and the lowest MBC value of 1.51 mg/ml
against E. coli. In the TLC study, 9 spots of methanol
leaf-extract of S. xanthocarpum were recorded with two
solvent systems. The phytochemicals of S. xanthocarpum,y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2015.08.006
S.S. Swain and R.N. Padhy380solasodine and stigmasterol glucoside had the highest
docking score values, 10.868 kcal/mol and
10.439 kcal/mol, respectively, against b-lactamase.
Conclusion: This study could prove in vitro antimicrobial
efficacy of 5 uncommon plants against MDR pathogenic
bacteria. Solasodine and stigmasterol glucoside were
computationally recorded as the best controlling chem-
icals from the plant S. xanthocarpum.
Keywords: Antibacterial efficacy; Medicinal plants; Molecu-
lar docking; Solanum xanthocarpum; b-lactamase
 2015 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Annoyance from infectious diseases caused by drug/
antibiotic resistant bacteria is commonplace in clinical
management.1,2 Oftentimes, newly added antibiotics control
infections from resistant bacteria; however, over time, strains
that are resistant to the new antibiotics also develop
continually.1 Thus, in the continual process of drug
development, several antibiotics, for example penicillin and
their derivatives, have been introduced by the structural
modification(s) of penicillin.3 Furthermore, the penicillin
group with the b-lactam ring (amoxicillin, ampicillin,
azlocillin, carbenicillin, cloxacillin, dicloxacillin,
flucloxacillin, mezlocillin, methicillin, nafcillin, oxacillin,
penicillins, piperacillin, temocillin and ticarcillin) as well as
the cephalosporin group of antibiotics have been developed
in progressive generations3; the cephalosporins had 5
generations, as listed: the first/second generations
(cefamandole, cefmetazole, cefonicid, cefotetan, cefoxitin,
cefprozil, cefuroxime, cefuzonam), the third generation
(cefcapene, cefdaloxime, cefdinir, cefditoren, cefetamet,
cefixime, cefmenoxime, cefodizime, cefotaxime, cefpimizole,
cefpodoxime, cefteram, ceftibuten, ceftiofur, ceftiolene,
ceftizoxime, ceftriaxone, cefoperazone, ceftazidime), the
fourth generation (cefclidine, cefepime, cefluprenam,
cefoselis, cefozopran, cefpirome, cefquinome) and the fifth
generation (ceftobiprole, ceftaroline). Similarly, among
other groups, aminoglycosides (e.g., amikacin, gentamicin,
amoxyclav, ampicillin), fluoroquinolones (e.g.,
ciprofloxacin, gatifloxacin, nalidixic acid, norfloxacin,
ofloxacin, etc.), glycopeptides (vancomycin and
cotrimoxazole) and several stand-alone antibiotics have
been introduced, which also have become progressively
moribund due to the development of drug resistance.4
Naturally, antibiotic-resistant bacteria have higher degrees
of virulence, compared with the corresponding wild strains,
and a multidrug resistant (MDR) bacterium that is resistant
to a number of antibiotics is intractable5 and sometimes
precipitates public health episodes, e.g., due to the
enteropathogen Clostridium difficile.6It should be noted that the horizontal gene transfer of
resistance character(s) causes movement to different bacteria
of the same, similar or different heritage, so much so that
progressively more antibiotic resistant bacteria emerge7,8; for
example, although it was once clinically known to be a
harmless commensal, the Gram-positive (GP) bacterium
Staphylococcus aureus has now become drug resistant to a
group of narrow-spectrum b-lactam antibiotics, the methi-
cillin. The resistant strain, called methicillin-resistant S.
aureus (MRSA), has become peripatetic and has caused
grievous problems in surgical site infections, burn site in-
fections, and urinary tract infections (UTI), which all lead to
bacteremia in the lungs, septicaemia and innards, such as
persistent lung infection and endocarditic, which cause
morbidity and unexpected mortality.9 The acquired
armamentaria by MRSA are resistant to most antibiotics
of most other groups, as reported from this hospital, which
could be labelled as MDR MRSA10; such strains are the
super-bug of the health domain. It has been further
observed in this hospital that the strains of Escherichia coli,
Klebsiella pneumoniae and Pseudomonas aeruginosa have the
causatives of major infectious agents in repeated studies of
surveillance.11,12 Even a metallo-b-lactamase strain of
K. pneumoniae was recorded to cause the mortality of a
neonate in this hospital.13
Our school has recorded a handful of plants that control
MDR strains of pathogenic bacteria, Enterococcus faecalis,
S. aureus (MRSA), E. coli, K. pneumoniae, P. aeruginosa and
a few more.14,15 Indeed, regardless of how well a bacterium
had picked up resistance to different groups of antibiotics,
such a strain was controlled consistently by crude extracts
of several plant species.11,16,17 Continuing this line of work,
the antibacterial efficacy of 21 medicinal plants used by an
Odishan aborigine group since before recorded history is
described here. For the screening work, ten pathogenic
bacteria have been isolated from clinical samples of
patients who were admitted to the intensive care unit
(ICU), wards and cabins of a hospital. The gargantuan
numbers of unexplored plants used by aborigines for their
health care needs, especially for infectious ailments, require
scientific validation as non-microbial antimicrobials for the
suitable use of selected lesser known and unknown plants of
the forest floor with hill-dwelling tribes, in modern drug
development for the crusade against MDR bacteria. A dis-
logistic approach to the phyto-drugs for their use in main-
stream medicine as ‘complementary medicine’ would be an
under-exploitation of medicines from a natural source.Materials and Methods
Collection of plants and extract preparations
Approximately 60 respondents from 25 hamlets of the
Eastern mountain range between Junagarh and Bhawani-
patna in the Kalahandi district, Odisha were interviewed in
the forest reviewed, and the ethnomedicinal information of
21 plants was documented. The snowball method of survey
and sampling was used, as previously followed.18 Collected
leaf samples were crushed to powder form; many 10-g leaf
powder samples were dissolved in an aliquot of 100-ml
methanol and incubated at 4 C for 72 h, and the
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trated in a rotary evaporator at 40 C, until a sticky mass was
obtained that was weighed and dissolved in an aliquot of
1.0 ml 10% v/v dimethyl sulfoxide (DMSO), and those were
stored at 4 C until further use.Isolation, identification of bacterial strains and antibiotic
sensitivity test
TwoGPs, E. faecalis, S. aureus, and 8 GNs, Acinetobacter
baumannii, Citrobacter freundii, Enterobacter aerogenes, E.
coli, K. pneumoniae, Proteus mirabilis, Proteus vulgaris and
P. aeruginosa, were used in this study. All of these bacteria
were directly isolated from urine samples of patients from
ICUs, wards and cabins at Institute of Medical Sciences and
Sum Hospital, Bhubaneswar, using an appropriate medium,
which was specific for each bacterium. All of the bacterial
strains were subjected to antibiotic sensitivity tests by the
KirbyeBauer’s disc diffusion method, using a 4-mm-thick
Mueller-Hinton (MH) agar (HiMedia, Mumbai) medium,
following the standard antibiotic susceptibility test chart of
Clinical Laboratory Standard Institute guidelines, 2011.19Antibacterial test of plant extracts
One strain from each bacterial species that showed resis-
tance to a maximum number of antibiotics was further used
for monitoring the antibacterial potentiality of plant extracts
with gentamicin 30 mg/ml, as the standard, by the agar-well
diffusion method, as detailed earlier.17 Antibacterial
activities were evaluated by measuring the diameter values
of zones of inhibition on a bacterial lawn due to a plant
extract; experiments of each solvent extract were conducted
three times, and the results of the third repetition are
presented. It was confirmed that 10% DMSO had no
inhibitory effect on any bacterium.Determinations of MIC and MBC of plant extracts
Minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) of the active plant extracts
were determined. Stock solutions of leaf extracts were pre-
pared at 100 mg/ml with 10% DMSO solution. Each stock
solution was diluted to obtain the final concentrations of
0.05, 0.13, 0.29, 0.67, 1.51, 3.41, 4.27, 9.63, 21.67 and
44.42 mg/ml. A separate experiment was conducted for each
plant-extract. An aliquot of 80 ml of each dilution of a plant-
extract was released to a well on a 96-welled (12  8) micro-
titre plate, along with an aliquot of 100-ml MH broth, an
aliquot of 20-ml bacterial inocula (109 CFU/ml) and a 5-ml
aliquot of 0.5% of 2,3,5-triphenyl tetrazolium chloride
(TTC). After pouring all of the above into a well, the micro-
plate was incubated at 37 C for 18 h. The development of
pink colouration due to TTC in a well indicated bacterial
growth, and the absence of the colour was taken to mean
inhibition of bacterial growth. The first well of the micro
plate was the control and did not have any plant extract. The
MIC value was noted at the well, where no colour was
manifested. Furthermore, bacteria from each well of the
micro plate were sub-cultured on a nutrient agar plate; thelevel of dilution, where no bacterial growth on the nutrient
agar plate was observed, was noted as the MBC value.11
Qualitative phytochemical analyses
Biochemical tests were performed with methanol extracts
of used medicinal plants for alkaloids, carbohydrates, sa-
ponins, flavonoids, steroids/terpenes, tannins and glycosides,
as detailed.20
Thin layer chromatography
The methanol extract of the Solanum xanthocarpum was
subjected to thin layer chromatography (TLC) analysis, to
separate the polar and non-polar phytocompounds,21 for
confirmation. Two solvent systems were used during TLC
work, (1) ethyl acetate: acetic acid: formic acid, 8:1.5:0.5,
v/v, and (2) chloroform: methanol, 8.5:1.5, v/v for
separation. The leaf-extract of S. xanthocarpum was further
used for TLC analysis. Precoated aluminium-backed silica
gel GF254 plates (MERCK, Germany) were used.
Molecular docking
The structure of the target protein, b-lactamase enzyme
(PDB ID: 1BT5) of E. coli resistant to b-lactam antibiotics,
was retrieved from Protein Data Bank (PDB) (http://www.
rcsb.org/pdb/home/home.do), and in addition, the struc-
ture and relevant information of 7 phytochemicals of
S. xanthocarpum were retrieved from the PubChem (http://
www.ncbi.nlm.nih.gov/pccompound) database, for a dock-
ing study. The AutoDock 4.2.6 and ArgusLab 4.0.1 software
were used for the molecular docking process; and the Pylon
and Discovery studio software were used for the protein-
ligand interactions. In this study, the b-lactamase enzyme is
the largest molecule against which the phytochemicals and
antibiotics were docked, individually as ligands. The ob-
tained docking score values could be used to predict the in-
dividual efficacy of each ligand against the enzyme.
Eventually, the pathogen E. coli could be computationally
predicted to be controlled by the phytochemicals, in parallel
with the efficacy of the antibiotic gentamicin.
Results
Ethnomedicinal information on 21 reported medicinal
plants were documented along with the details of the mo-
dalities of crude extracts as medicine for several ailments,
which were used by local ethnic aborigine tribes (Table 1).
All of these plants are in use for treating cough, diarrhoea,
diabetes, bronchitis, fever, gum bleed, ulcers, killing
worms, constipation, piles and urinary tract infections.
However, parts of the majority of the plants (17 of 21
plants) are not edible as medicines.
Identification of pathogenic bacterial strains was per-
formed with gross colony morphologies (Table 2) and
biochemical test results (Table 3), along with those of the
corresponding MTCC strains in reference. For example,
the GP bacterium, S. aureus, was catalase and coagulase
positive, while the GP bacterium E. faecalis was catalase
and coagulase negative along with positivity to the bile
Table 1: Ethnomedicinal uses of 21 plants from aborigines of Kalahandi district, Odisha.
Sl. No Plant name; specimen
number
Family Local name;
parts used
Ethnomedicinal uses Yield of
ME (mg)
1. Abelmoschus Crinitus
Wall.; KLD126
Malvaceae Bana bhendi;
Root, leaf.
Root is used in dysentery and diarrhoea. Leaves are
used for treating diabetes, jaundice, cholera,
asthma.
0.25
2. Ageratum conyzoides
L.; KLD139
Asteraceae Pokasungha;
leaf, root
Leaf paste is used for allergy, scabies and anti-
infection. The juice of the root is used for
dysentery.
0.19
3. Annona squamosa L.
(Ed); KLD105
Annonaceae Sitaphala;
leaf, bark.
Bark is used for urinary infections. Leaf is used for
diarrhoea, fever, inflammation, blood vomiting,
cough, vomiting, wounds and ulcers.
0.20
4. Aerva lanata (L.) Juss.
Ex Sch. (Ed); KLD187
Amaranthaceae Paunsia;
leaf, root
Leaf and root is used in cough, painful discharge of
urine, headache, liver congestion, jaundice.
0.23
5. Buchanania latifolia
Spreng.; KLD239
Anacardiaceae Chara,
leaf
Leaf is used as vermifuge, antiseptic and chicken
pox and acne.
0.19
6. Cardiospermum
halicacabum L.
KLD274
Sapindaceae Mandibatha;
leaf, whole plant
Leaf is used as arthritis, pain relief, ear ache,
purulent discharge, dandruff and diarrhoea.
0.23
7. Careya arborea Roxb.;
KLD278
Lecythidaceae Kumbhi,
leaf, bark
Leaf is used to protect stomach from ulcer
formation. Bark is useful in diarrhoea, blood
dysentery.
0.26
8. Cleome viscosa L.;
KLD282
Capparaceae Banasorisha;
leaf
Leaf is used for eyesore, piles, dysentery and
rheumatism.
0.23
9. Curcuma aromatic
Salisb.; KLD296
Zingiberaceae Bana haladi;
Leaf, rhizomes
Leaf is used for skin infection and anthelmintic.
Rhizomes are used for burning of stomach.
0.21
10. Cuscuta reflexa Roxb.;
KLD299
Cuscutaceae Nirmuli;
whole plant
It is used in the treatment of diarrhoea, dysentery,
rheumatism swellings, and joint pain.
0.24
11. Dioscorea bulbifera L.;
KLD304
Dioscoreaceae Pitta alu;
leaf, rhizome
Leaf is used in skin and scabbing activities.
Rhizomes are used in piles, cough and constipation.
0.27
12. Diospyros peregrine
(Gaertn.) Guerke;
KLD319
Ebenaceae Mankada kendu;
Fruit, leaf
Fruit juice is used for diarrhoea, dysentery. Leaves
are used in infection, asthma and ulcers.
0.28
13. Glycosmis arborea
(Roxb.) DC; KLD502
Rutaceae Bana lembu;
leaf
Leaves are useful for dysentery, piles, and
infections.
0.25
14. Holarrhena pubescens
(Buch. Ham.)
Wall.exDon.; KLD359
Apocynaceae Keruon;
leaf, bark
Bark and leaves are used in treatment of piles, skin
diseases, urinary troubles, diarrhoea.
0.19
15. Nicotiana tabacumL.;
KLD664
Solanaceae Dhuanpatra;
leaf
In a snake bite, the leaf is taken in such a way that
poison does not spread.
0.27
16. Ocimum tenuiflorum L.
(Ed); KLD541
Lamiaceae Karpur tulsi;
leaf, whole plant
Leaves are useful for cold, cough, tonsillitis, fever,
asthma and bronchitis.
0.29
17. Phoenix pusilla Roxb.
(Ed); KLD280
Arecaceae Banakhajuri;
leaf, flower, root
Leaves are useful in fever. Flowers are useful in
asthma, inflammations. Its root is used for asthma,
bronchitis.
0.17
18. Senna alata(L.) Roxb.;
KLD 337
Fabaceae Dadmari;
leaf, flower
Leaves are used for ring worm, skin infection and
constipation. Flower used for eczema.
0.14
19. Solanum xanthocarpum
Schrad & Wend.
KLD772
Solanaceae Bhejibaigana;
leaf, flower
Leaf juice with black pepper and honey is taken on
an empty stomach for a week to cure cough and
tonsillitis. Flowers fried in fat are chewed everyday
to cure asthma.
0.29
20. Toddalia asiatica (L.)
Lam.; KLD746
Rutaceae Tundipoda;
leaf
Leaf is useful in skin diseases, burning sensations,
dry cough, dysentery, inflammation, boils, and
ringworm infection.
0.18
21. Ziziphus oenoplia (L.)
Mill. (Ed); KLD694
Rhamnaceae Kanteikoli;
leaf, bark
Leaves used for wound healing, skin infection.
Bark used for dysentery and sore throats.
0.20
Ed, edible; ME, methanol extract.
S.S. Swain and R.N. Padhy382esculin test. Among the GN strains, E. coli (Figure 1) cells
were positive to tests for catalase, indole, MR and nitrate
production, while in the TSI test, the production of acid in
the slant and gas in the butt of the tube occurred, and the
E. coli cells were negative to other biochemical tests.P. aeruginosa was identified by its positivity to catalase,
oxidase, citrate, urease and nitrate tests, while it had
negativity to the indole, MR and VP tests. The remaining
bacteria were also identified using similar features (Tables 2
and 3).
Table 2: Colony characteristics of two Gram-positive and eight Gram-negative pathogenic bacteria isolated from clinical samples.
Bacterium MTCC strain Media used Colony characteristics
Enterococcus faecalisa 439 Blood agar Grey coloured, round, gamma haemolytic colonies
Staphylococcus aureusa 7443 Blood agar Medium to large, smooth, entire, slightly raised, creamy yellow,
with green/beta haemolytic colonies
Nutrient agar As above without haemolytic activity
Acinetobacter baumannii 1425 Nutrient agar Colourless smooth, opaque, raised and pinpoint
MacConkey agar Colourless smooth, opaque, raised, NLF
CLED agar Blue coloured opaque raised NLF
Citrobacter freundii 1658 MacConkey agar Late LF light pink after 48 h
Enterobacter aerogenes 2990 Blood agar White convex with gammadhaemolysis
MacConkey agar LF, mucoid
Escherichia coli 443 Nutrient agar Flat dry, irregular
MacConkey agar LF, flat dry pink, irregular
EMB agar Purple coloured, flat dry, irregular colonies, with metallic green colour.
Blood agar Swarms on blood agar with betadhaemolysis
CLED agar Translucent blue
Klebsiella pneumoniae 4031 MacConkey agar LF, pink, mucoid
CLED agar Yellow mucoid
Proteus mirabilis 739 MacConkey agar NLF light pink after 48 h
Blood agar Swarms on blood agar with betadhaemolysis
CLED agar Translucent blue
Proteus vulgaris 1771 Blood agar Swarms on blood agar with betadhaemolysis
CLED agar Translucent blue
Pseudomonas aeruginosa 1688 Nutrient agar Large, irregular opaque with bluish green pigment
a Gram-positive bacteria; MTCC, microbial type culture collection; CLED, cysteine lactose electrolyte deficient; EMB, eosin methylene
blue; LF, lactose fermenting; NLF, non-lactose fermentation.
Table 3: Biochemical identifications of the isolated Gram-positive and Gram-negative bacteria.
Bacterium Catalase Oxidase Coagulase Indole MR VP Citrate Urease TSI Nitrate Bile esculin
E. faecalis  Nd  Nd Nd Nd Nd Nd Nd Nd þ
S. aureus þ Nd þ Nd Nd Nd Nd Nd Nd Nd Nd
A. baumannii þ  Nd   þ þ V Nd  Nd
C. freundii þ  Nd  þ  þ  A/A H2S þ Nd
E. aerogenes þ  Nd   þ þ  A/A þ Nd
E. coli þ  Nd þ þ    A/AG þ Nd
K. pneumoniae þ  Nd   þ þ þ A/AG þ Nd
P. mirabilis þ  Nd  þ  þ þ K/AH2S þ Nd
P. vulgaris þ  Nd þ þ  þ þ K/AH2S þ Nd
P. aeruginosa þ þ Nd    þ þ Nd þ Nd
MR, methyl red test; VP, VogeseProskauer test; TSI, triple sugar iron test; V, variable; A/A, acid in slant and butt; A/AGH2S, acid in slant
and butt with H2S gas production; A/AG, acid in slant and butt with gas production; K/A H2S, alkali in slant and butt with H2S gas
production; Nd, not done; þ, positive; , negative.
In vitro antibacterial efficacy of plants used by Indian aborigine tribe against pathogenic bacteria 383The antibiotic profile of each pathogenic bacterium was
determined using specified antibiotic discs (Table 4).
E. faecalis was resistant to 16 and S. aureus was resistant
to 12 of 18 prescribed antibiotics. Among the 8 GN
isolates, A. baumannii was resistant to 9 antibiotics,
C. freundii and K. pneumoniae were resistant to 10
antibiotics, E. coli and P. vulgaris were resistant to 11
antibiotics, and E. aerogenes was resistant to 13 of the
total 14 antibiotics used. Details of individual
antibiograms of individual bacterium were determined
(Table 4). Clearly, all of the isolated bacterial strains were
floridly MDR.
Diameter values of zones of inhibition due to methanol
extracts from the leaves of 21 plants against MDR strains of10 bacteria were recorded (Table 5, Figure 2). The most
effective 5 plants, which caused the size of the zone of
inhibition (an effective controlling capacity) to be 21e
27 mm, were Buchanania latifolia, Careya arborea, Ocimum
tenuiflorum, Senna alata and S. xanthocarpum, for any GP
or GN MDR bacterial strain. The methanol leaf-extract of
the plant, B. latifolia, had the highest size for the zone of
inhibition of 25 mm, against S. aureus, and the lowest value
of 15 mm against P. vulgaris. The methanol leaf-extract of
C. arborea had the highest size of the zone of inhibition,
25 mm, against S. aureus, which had the lowest value of
14 mm against C. freundii. The methanol leaf-extract of
O. tenuiflorum had the highest size of the zone of inhibition,
26 mm, against S. aureus, and the lowest value of 14 mm was
Figure 1: Escherichia coli in MacConkey agar.
Table 4: Prescribed antibiotic susceptibility results against isolated G
Bacterium Susceptibility to prescribed antibiotics
Amino-
glycosides
b-lactams Cephalo-
sporins
Fluo
Ac Ge Ak Am Ox Pt Ce Cf Of
E. faecalis R R R MS R R R R R
S. aureus R R R MS MS R R R R
A. baumannii R R R S ND R R R R
C. freundii S R R R ND R R R S
E. aerogenes R R R R ND R R R R
E. coli R R R R ND S R R R
K. pneumoniae R R R R ND R R R R
P. mirabilis S R R R ND S R R S
P. vulgaris R R R S ND R R S S
P. aeruginosa R R R R ND R R R S
R, Resistant; S, Sensitive; MS, moderately sensitive; ND, not done.
ampicillin 10; Cd, clindamycin 2; Cf, cefpodoxime 10; Ch, chloramphen
10; Gt, gatifloxacin 5; Le, levofloxacin 5; Lz, linezolid 30; Of, ofloxac
floxacin 10; Tei, teicoplanin 5; Va, vancomycin 30.
Table 5: Antibacterial activity of methanol leaf extracts of 21 plants b
of inhibition (mm).
Bacteria Diameter size of zone of inhibition by methanol leaf
1 2 3 4 5 6 7 8 9 10
E. faecalis 17 19 19 14 24 18 22 17 18 16
S. aureus 18 18 16 14 25 14 25 18 17 14
A. baumannii 17 21 20 18 20 e 17 18 18 13
C. freundii 20 e 17 e 16 e 14 14 e e
E. aerogenes 16 17 19 e 17 13 18 16 19 18
E. coli 21 14 14 19 19 15 20 15 16 17
K. pneumoniae 17 17 e 17 20 13 15 13 18 18
P. mirabilis 18 18 14 17 17 e 19 e 17 19
P. vulgaris 14 e 20 e 15 16 16 18 19 18
P. aeruginosa 19 17 17 19 21 18 23 18 20 20
Ge; gentamicin 30 mg/ml used as the control. The numbers 1 to 21
measurements of the zone of inhibition in triplicate due to methanol le
S.S. Swain and R.N. Padhy384against P. mirabilis. The methanol-extract of S. alata had the
highest value of the size of the zone of inhibition, which was
25 mm, against E. coli and the smallest size of the zone of
inhibition was 13 mm against A. baumannii. The methanol
leaf-extract of S. xanthocarpum had the highest size of the
zone of inhibition, which was 25 mm, against E. coli, and the
lowest value of 18 mm was against E. aerogenes. The meth-
anol leaf-extracts of the plants Abelmoschus crinitus, Ager-
atum conyzoydes, Annona squamosa, Curcuma aromatica,
Dioscorea bulbifera, Diospyros peregrine, Glycosmis arborea,
Holarrhena pubescens, Cuscuta reflexa and Ziziphus oenoplia
showed moderate control capacity. Methanol leaf-extracts of
the remaining 6 plants, Aerva lanata, C. halicacabum,
C. viscose, C. reflexa, Phoenix pusilla and Toddalia asiatica,
were comparatively less effective in controlling the MDR
strains of the isolated pathogenic bacteria.
Among 21 plants, S. xanthocarpum had 0.67 mg/ml as the
lowest MIC value and 1.51 mg/ml as the lowest MBC value
against E. coli, and this plant had the MIC value of 3.41 mg/
ml and the MBC value of 4.27 mg/ml for E. aerogenes. A
lower MIC/MBC value signifies that a minimum amount ofram-positive and Gram-negative bacteria.
roquinolones Glyco-
peptides
Lincos-
amide
Sulfonamide Stand
alones
Le Nx Gt Tei Va Cd Cot Ch Lz
R R R R S R R R R
R R R MS MS S R R S
R S S ND ND ND S R S
R R MS ND ND ND R R S
R R R ND ND ND R MS R
R R R ND ND ND S R S
R S S ND ND ND R MS S
R S MS ND ND ND R S R
R R S ND ND ND S R R
R R MS ND ND ND R R S
Antibiotics (mg/disc): Ac, amikacin 30; Ak, amoxyclav 30; Am,
icol 30; Cot, co-trimoxazole 25; Ce, ceftriaxone 30; Ge, gentamicin
in 5; Ox, oxacillin 1; Pt, piperacillin/tazobactam 100/10; Nx, nor-
y the agar-well diffusion method, measured as the size of the zone
extracts of plants
11 12 13 14 15 16 17 18 19 20 21 Ge
19 18 18 19 17 21 19 20 23 18 18 30
20 14 14 17 18 26 15 24 21 17 17 28
17 20 16 e 17 17 13 13 19 18 19 22
16 14 14 18 19 18 e 15 19 20 20 26
17 15 19 e 13 20 18 18 18 18 e 24
18 18 16 16 14 16 e 25 25 e 18 26
20 16 19 18 18 19 18 21 23 19 19 26
18 e 18 17 17 14 e 17 19 e 18 28
16 17 e e 14 17 16 15 19 18 16 26
18 19 17 20 14 24 17 21 20 e 21 28
are serial numbers of plants given in Table 1; the values are the
af extracts. The “e” sign denotes no activity.
Figure 2: A, Solanum xanthocarpum; B, Diospyros peregrine; C, Senna alata, D, Ocimum tenuiflorum.
In vitro antibacterial efficacy of plants used by Indian aborigine tribe against pathogenic bacteria 385plant extract was used, whereas a higher value signifies the
use of a larger amount of plant extract for the control of
any bacterium. The MIC and MBC values due to the
methanol extracts of the remaining plants were recorded
(Table 6a, b, c).
Qualitative phytochemical analysis was performed for
these 21 plants. All of these plants contained phytochemicals,Table 6a: MIC and MBC values by methanol leaf extracts of the fir
Bacterium MIC and MBC values of plant numbers 1 to 7
1 2 3
MIC MBC MIC MBC MIC MBC
E. faecalis 4.27 9.63 3.41 4.27 3.41 4.27
S. aureus 3.41 4.27 3.41 4.27 4.27 9.63
A. baumannii 4.27 9.63 1.51 3.41 3.41 4.27
C. freundii 3.41 4.27 e e 4.27 9.63
E. aerogenes 4.27 9.63 4.27 9.63 3.41 4.27
E. coli 1.51 3.41 4.27 9.63 4.27 9.63
K. pneumoniae 4.27 9.63 4.27 9.63 e e
P. mirabilis 3.41 4.27 3.41 4.27 9.63 21.67
P. vulgaris 9.63 21.67 e e 3.41 4.27
P. aeruginosa 3.41 4.27 4.27 9.63 4.27 9.63alkaloids, glycosides flavonoids, carbohydrates, terpenoids,
steroids, and tannins, which could be attributed to their
recorded significant antibacterial activities (Table 7). Using
the first solvent system, 5 spots from the methanol extracts
of S. xanthocarpum were identified in the TLC plate, which
had the following retardation factor (Rf) values: 0.19, 0.22,
0.32, 0.63 and 0.74. With the second solvent system, therest seven plants against pathogenic bacteria (mg/ml).
4 5 6 7
MIC MBC MIC MBC MIC MBC MIC MBC
9.63 21.67 0.67 1.51 3.41 4.27 1.51 3.41
9.63 21.67 0.67 1.51 9.63 21.67 0.67 1.51
4.27 9.63 3.41 4.27 e e 4.27 9.63
e e 4.27 9.63 e e 9.63 21.67
e e 4.27 9.63 9.63 21.67 3.41 4.27
3.41 4.27 3.41 4.27 4.27 9.63 3.41 4.27
4.27 9.63 3.41 4.27 9.63 21.67 4.27 9.63
4.27 9.63 4.27 9.63 e e 3.41 4.27
e e 4.27 9.63 4.27 9.63 4.27 9.63
3.41 4.27 1.51 3.41 3.41 4.27 1.51 3.41
Table 6b: MIC and MBC values by methanol leaf extracts of the second seven plants against pathogenic bacteria (mg/ml).
Bacterium MIC and MBC values of plant numbers 8 to 14
8 9 10 11 12 13 14
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
E. faecalis 4.27 9.63 3.41 4.27 4.27 9.63 3.41 4.27 3.41 4.27 3.41 4.27 3.41 4.27
S. aureus 3.41 4.27 4.27 9.63 9.63 21.67 3.41 4.27 9.63 21.67 9.63 21.67 4.27 9.63
A. baumannii 3.41 4.27 3.41 4.27 9.63 21.67 4.27 9.63 3.41 4.27 4.27 3.41 e e
C. freundii 9.63 21.67 e e e e 4.27 9.63 9.63 21.67 9.63 21.67 3.41 4.27
E. aerogenes 4.27 9.63 3.41 4.27 3.41 4.27 4.27 9.63 4.27 9.63 3.41 4.27 e e
E. coli 4.27 9.63 4.27 9.63 4.27 9.63 3.41 4.27 3.41 4.27 4.27 3.41 4.27 9.63
K. pneumoniae 9.63 21.67 3.41 4.27 3.41 4.27 3.41 4.27 4.27 9.63 3.41 4.27 3.41 4.27
P. mirabilis e e 4.27 9.63 3.41 4.27 3.41 4.27 e e 3.41 4.27 4.27 9.63
P. vulgaris 3.41 4.27 3.41 4.27 3.41 4.27 4.27 9.63 4.27 9.63 e e e e
P. aeruginosa 3.41 4.27 3.41 4.27 3.41 4.27 3.41 4.27 3.41 4.27 4.27 3.41 3.41 4.27
Table 6c: MIC and MBC values by methanol leaf extracts of the third seven plants against pathogenic bacteria (mg/ml).
Bacterium MIC and MBC values of plant numbers 15 to 21
15 16 17 18 19 20 21
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
E. faecalis 4.27 9.63 1.51 3.41 3.41 4.27 3.41 4.27 1.51 3.41 3.41 4.27 3.41 4.27
S. aureus 3.41 4.27 0.67 1.51 4.27 9.63 0.67 1.51 1.51 3.41 4.27 9.63 4.27 9.63
A. baumannii 4.27 9.63 4.27 9.63 9.63 21.67 9.63 21.67 3.41 4.27 3.41 4.27 3.41 4.27
C. freundii 3.41 4.27 3.41 4.27 e e 4.27 9.63 3.41 4.27 3.41 4.27 3.41 4.27
E. aerogenes 9.63 21.67 3.41 4.27 3.41 4.27 3.41 4.27 3.41 4.27 3.41 4.27 e e
E. coli 9.63 21.67 4.27 9.63 e e 0.67 1.51 0.67 1.51 e e 3.41 4.27
K. pneumoniae 3.41 4.27 3.41 4.27 3.41 4.27 1.51 3.41 1.51 3.41 3.41 4.27 3.41 4.27
P. mirabilis 4.27 9.63 9.63 21.67 e e 4.27 9.63 3.41 4.27 e e 3.41 4.27
P. vulgaris 9.63 21.67 4.27 9.63 4.27 9.63 4.27 9.63 3.41 4.27 3.41 4.27 4.27 9.63
P. aeruginosa 9.63 21.67 0.67 1.51 4.27 9.63 1.51 3.41 3.41 4.27 e e 1.51 3.41
S.S. Swain and R.N. Padhy386were 4 rising spots, which had the Rf values of 0.27, 0.38, 0.54
and 0.72, in the TLC plate.
The molecular docking of the b-lactamaseephytochem-
ical interaction was aimed at locating the potentiality of
some of the leading phytochemicals. Phytocompounds of
S. xanthocarpum, solasodine and stigmasterol glucoside had
the highest docking score values, 10.868 kcal/mol
and 10.439 kcal/mol, respectively, against b-lactamase of
E. coli, as the target protein (Figure 3). It was recorded that
the seven phytochemicals could be arranged as being
effective in their decreasing order of docking score value,
solasodine (10.868) > stigmasterol glucoside
(10.439) > esculin (8.744) > apigenin (8.724) > lupeol
(8.495) > scopoletin (8.399) > caffeic acid (8.341),
which is based on the negativity of the docking score
values; a more negative docking score value is selected to
be the more active compound (Table 8). Thus, the
development of plant derivative/phytochemical(s) as
antibacterial agents could be indicated by using the tools of
bioinformatics, thus eliminating the time and resources of
the “hit-and-miss” method required for drug development.
Thus, this computational attempt to use the tools of
bioinformatics in identifying suitable phytochemical(s),
especially from S. xanthocarpum, for use as alternative
agents from plant derivative drugs to address suitably and
overcome antibiotic resistance (see Table 8).Discussion
In Indian Ayurveda, Chinese traditional medicine (TM),
and similarly in several countries, a large number of plants,
based on ethnobotanical information, are in use as crude
medicines locally, while a plethora of pure phytochemicals
have lent themselves to the modern drug development pro-
cess against infectious and non-infectious diseases.22 Today,
the concept of TM as complementary and alternative
medicine (CAM) has been popular worldwide.23,24
Consequently, the World Health Organization (WHO) has
issued mandates that describe plants as the best source of a
variety of drugs.24 Indeed, several formulations of crude
drugs of individual plants are available on the market
worldwide.
In the present study, plants such as A. squamosa and O.
tenuiflorum have antimicrobial and antioxidant activities;
such plants are suitable candidates for being used as CAM.
The complexity of phytochemicals in a crude extract is due to
flavonoids, saponins, glycosides, terpenoids, steroids and
phenols and other compounds; flavonoids are less toxic than
alkaloids, generally.25 Thus, an edible plant, such as
A. squamosa, A. lanata, O. tenuiflorum, P. pusilla, or Z.
oenoplia, should have limited alkaloid content, and
basically, an edible plant contains a substantial amount of
flavonoids holistically. In acute toxicity or host toxicity
Figure 3: A, Three-dimensional structure of protein-ligand interaction of solasodine isolated from S. xanthocarpum against b-lactamase
enzyme of E. coli (PDB ID: 1BT5) with surface view using Discovery studio Visualizer 3.1 software; B, the same without surface view with
solasodine interacting with target enzyme, b-lactamase.
Table 7: Qualitative phytochemical analysis of the methanol leaf extracts of the 21 medicinal plants.
Plants Alkaloids Glycosides Terpenoids Carbohydrates Tannins Flavonoids Steroids
A. crinitus þ  þ þ þ þ þ
A. conyzoides þ  þ  þ þ þ
A. squamosa þ þ þ  þ þ 
A. lanata þ  þ þ þ þ þ
B. latifolia  þ þ þ þ þ þ
C. halicacabum þ þ þ þ  þ þ
C. arborea þ þ     þ
C. viscosa þ þ þ  þ  
C. aromatica   þ þ   
C. reflexa þ   þ  þ 
D. bulbifera þ þ   þ þ 
D. peregrina þ    þ þ 
G. arborea þ  þ   þ þ
H. pubescens  þ  þ  þ 
N. tabacum þ þ   þ þ 
O. tenuiflorum þ  þ  þ þ 
P. pusilla þ  þ þ þ þ þ
S. alata  þ þ    þ
S. xanthocarpum þ þ þ þ þ þ þ
T. asiatica   þ  þ þ þ
Z. oenoplia þ  þ þ  þ þ
“þ” sign denotes presence, and “”sign denotes absence of the compound in a plant.
In vitro antibacterial efficacy of plants used by Indian aborigine tribe against pathogenic bacteria 387studies in mammals, acting in accordance with
pharmacological guidelines is the most suitable approach
for an individual crude extract of a plant. Obviously,
phyto-drugs are cost effective in comparison with chemical
drugs, and those could be promoted as CAM after host
toxicity testing. An example of the in silico use of phyto-
chemicals enhances the antibacterial activity/potentiality of
rout antibiotics acting as a drug efflux pump.26 In a study,aqueous and methanol extracts of the plant, Grewia
serrulata, had been reported repeatedly in Wistar Albino
rats in toxicity testing attempts, and this plant was taken to
be non-toxic.27 Inherently, alkaloids are more toxic, and
flavonoids are curatives, in general. Based on specific
requirements, any of the phytochemicals are useful as
drugs; for example, plant alkaloids are used against
malaria, while flavonoids are used against hyperglycaemia.
Table 8: Structure of and information on the selected isolated bioactive compounds of S. xanthocarpum along with individual protein-
ligand docking score values against b-lactamase of E. coli.
Name; (chemical class) Information Chemical structure Docking score (kcal/mol)
Apigenin; (F) MW: 270.2369 g/mol
MF: C15H10O5
H-bond donor: 3
H-bond acceptor: 5
PubChem ID: CID 5280443
8.724
Caffeic acid; (P) MW: 180.15742 g/mol
MF: C9H8O4
H-bond donor: 3
H-bond acceptor: 4
PubChem ID: CID 689043
8.341
Esculin; (C) MW: 340.28214 g/mol
MF: C15H16O9
H-Bond donor: 5
H-Bond acceptor: 9
PubChem ID: CID 5281417
8.744
Lupeol; (T) MW: 426.7174 g/mol
MF: C30H50O
H-Bond donor: 1
H-Bond acceptor: 1
PubChem ID: CID 259846
8.495
Scopoletin; (C) MW: 192.16812 g/mol
MF: C10H8O4
H-bond donor: 1
H-bond acceptor: 4
PubChem ID: CID 5280460
7.399
Solasodine; (A) MW: 413.63582 g/mol
MF: C27H43NO2
H-Bond donor: 2
H-Bond acceptor: 3
PubChem ID: CID 442985
10.868
Stigmasterol glucoside; (S) MW: 574.83142 g/mol
MF: C35H58O6
H- bond donor: 4
H- bond acceptor: 6
PubChem ID: CID 6602508
10.439
A, alkaloid; C, coumarin, F, flavonoid; P, phenol; S, steroid; T, terpenoid and H-bond donor, hydrogen bond acceptor; H-bond acceptor,
hydrogen bond donor; MF, molecular formula; MW, molecular weight; chemical structures were retrieved from PubChem database.
S.S. Swain and R.N. Padhy388In the present docking attempt, one alkaloid and a sterol
were the most effective ligands.
An example of the synergistic use of methanol leaf-extract
of Combretum albidum and antibiotic ceftriaxone in con-
trolling ceftriaxone-resistant of P. aeruginosa in vitro was
demonstrated.28 Similarly, extracts of 7 Cameroonian spice
plants were described as having synergistic effects against
the antibiotic-resistant pathogenic bacteria, Providencia
stuartii, P. aeruginosa, K. pneumoniae, E. coli, E. aerogenes
and Enterobacter cloacae.29 Thus, the most effective plantscould be used synergistically with mainstream medicine
against MDR bacteria.
Currently, the drug discovery process has been revolu-
tionized by the computational molecular docking method.30
For this purpose, the target molecule against which a suitable
drug is to be aimed is retrieved from the protein database as
the ‘three-dimensional (3D) structure’. If necessary, the
structure of the target protein could be modified
computationally. However, the target protein is basically a
larger molecule against which possible control agents such
In vitro antibacterial efficacy of plants used by Indian aborigine tribe against pathogenic bacteria 389as ligands are docked. The target-ligand docking interaction
involves docking score values that are expressed as kcal/
mol.31 In the present system’s docking study, the b-lactamase
enzyme was the target protein against which the
phytochemicals apigenin, caffeic acid, esculin, lupeol,
scopoletin, solasodine and stigmasterol glucoside were
docked. The b-lactam group of antibiotics is frequently
used in the clinic for the control of infectious episodes
from GN bacteria. Frequent reports of resistance to these
antibiotics are due to the capability of the production of b-
lactamases by resistant bacterial strains, which degrade the
b-lactam ring. Thus, this enzyme is a putative target for
drug development modules.32 Phytochemicals, for example,
alkaloid, phenol and terpenoids, inhibit any specific
bacterial target and work against the cell wall; and
flavonoids and tannins target the inhibition of a specific
bacterial enzyme.33 Moreover, S. xanthocarpum chemicals
rising as spots on the TLC plate might be effectively
capable of controlling the MDR bacteria. From the
docking score values, the ligand with the minimum docking
score values was solasodine and stigmasterol glucoside of
S. xanthocarpum, which were taken as suitable ligands, in
other words, as the leading antibacterials.
Conclusions
Hidden ethnomedicinal information of aborigines could
be further validated, and the most effective plant(s) could be
exploited for the preparation of complementary drugs. From
21 plants that were monitored for antimicrobial activity, 5
plants may be useful as sources of non-microbial antibacte-
rials; specifically, S. xanthocarpum was observed as the best
plant based on the in vitro study. Blithely, from the molecular
docking approach, its solasodine and stigmasterol glucoside
were the most promising phytochemicals against b-
lactamase.
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